A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours uri icon

autores

  • RUI MANUEL VIEIRA REIS
  • Baruchel, S.
  • Reis, R. M.
  • Martinho, Olga
  • Sharp, J. R.
  • Bartels, U.
  • Hukin, J.
  • Odame, I.
  • Portwine, C.
  • Strother, D.
  • Aksoy-Aksel, A.
  • Fryer, Chris

data de publicação

  • janeiro 1, 2009